- Home
- OIS vs VNDA Comparison
OIS vs VNDA Comparison
Compare OIS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OIS | VNDA |
|---|---|---|
| Founded | 1995 | 2002 |
| Country | United States | United States |
| Employees | 2172 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.6M | 411.3M |
| IPO Year | 2000 | 2005 |
Fundamental Metrics
Financial Performance| Metric | OIS | VNDA |
|---|---|---|
| Price | $8.87 | $6.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $14.00 | ★ $14.90 |
| AVG Volume (30 Days) | 819.2K | ★ 1.1M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,088,133,000.00 | $216,105,000.00 |
| Revenue This Year | $3.12 | $21.35 |
| Revenue Next Year | $5.89 | $37.40 |
| P/E Ratio | $451.00 | ★ N/A |
| Revenue Growth | ★ 62.26 | 8.72 |
| 52 Week Low | $4.23 | $4.14 |
| 52 Week High | $14.50 | $9.91 |
Technical Indicators
Market Signals| Indicator | OIS | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 34.30 | 38.23 |
| Support Level | $8.60 | $5.73 |
| Resistance Level | $11.86 | $7.76 |
| Average True Range (ATR) | 0.46 | 0.31 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 11.76 | 12.18 |
Price Performance
Historical ComparisonAbout OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.